Sandra Demaria

32PUBLICATIONS
138CO-AUTHORS
Radiation therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical Trial.

|Apr 05, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer.

Sylvia Adams, Sandra Demaria, Darawan Rinchai

|Dec 11, 2024
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesis.

Aitziber Buqué, Norma Bloy, Giulia Petroni

|Sep 20, 2023
CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response.

Maud Charpentier, Silvia Formenti, Sandra Demaria

|Aug 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.

Joseph Willis, Robert A Anders, Toshihiko Torigoe

|Aug 24, 2023
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors.

Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier

Pageof 6

Frequent Collaborators

8 joint publications

Silvia Formenti

5 joint publications

Xi Kathy Zhou

5 joint publications

Sunil S Badve

5 joint publications

Sherene Loi